EMCURE:NSE
Emcure Pharmaceuticals Ltd
2 348,00 INR
arrow_upward
+1,45%(+33,60) 1D
13-ноя., 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
2 325,00 INR
High
2 395,00 INR
Low
2 315,40 INR
Mkt. cap
447,37 млд
Avg. vol.
229,26 миң
Volume
294,54 миң
Dividend
0,15%
Quarterly dividend
0,90 INR
Ex-dividend date
2026-ж., 4-сен.
P/E ratio
49,29
52-wk high
2 429,90 INR
52-wk low
1 312,30 INR
EPS
47,64 INR
No. of employees
7 миң
Open
2 325,00 INR
High
2 395,00 INR
Low
2 315,40 INR
Mkt. cap
447,37 млд
Avg. vol.
229,26 миң
Volume
294,54 миң
Dividend
0,15%
Quarterly dividend
0,90 INR
Ex-dividend date
2026-ж., 4-сен.
P/E ratio
49,29
52-wk high
2 429,90 INR
52-wk low
1 312,30 INR
EPS
47,64 INR
No. of employees
7 миң
News stories
From web sources and news partners
BigGo Finance
·
1 саат мурун
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
TradingKey
·
11 саат мурун
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
The Motley Fool
·
22 саат мурун
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
StoneX
·
2 күн мурун
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6,91 миң
Founded1981-ж., 16-апр.
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteemcure.com